Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 334
H List of Background Papers The following background papers (listed alphabetically by author) were prepared for the Committee on a National Strategy for AIDS. Copies of the papers are available from the Institute of Medicine, 2101 Constitution Avenue, NW, Washington, DC 20418. AIDS and Biomedical Research: A Comparative Analysis Evridiki Chatziandreou and John D. Graham, Ph.D. Beyond the Political Model of Reporting: Non-Specific Symptoms in Media Communications About AIDS William A. Check, Ph.D. Genetic Variation in AIDS Viruses John M.Coffin,Ph.D. AIDS Among Intravenous Drug Users: Current Research in Epidemiol- ogy, Natural History, and Prevention Strategies Don C. Des Jarlais, Ph.D. Animal Models for AIDS and Their Use for Vaccine and Drug Develop ment Ronald C. Desrosiers, Ph.D., and Norman L. Letvin, M.D. The Human T-Cell Lymphotropic Virus Type-III tHTLV-III) and Drug Abusers Harold M. Ginzburg, M.D., J.D., M.P.H., and Stanley H. Weiss, M.D. The AIDS Epidemic: A Projection of Its Irripact on Hospitals, 1986-1991 Jesse Green, Ph.D., Madeleine Singer! M.P.H., and Neil Wintield, Ph.D. 334
OCR for page 335
APPENDIX H 335 Cultural Practices Contributing to the Transm Daniel B. Hrdy, M.D., Ph.D. Drug Use After Drug Abuse Treatment: Followup of 1979-1980 TOPS Admission Cohorts Robert L. Hubbard, Ph.D., Mary Ellen Marsden, Ph.D., Elizabeth Cavanaugh, and J. Valley Rachal The NIH Research Effort on AIDS: To What Extent Has It Been Achieved by Reprogramming Funds Originally Allotted for Other Purposes? Richard M. Krause, M.D. Ethical Dilemmas About Intensive Care in Patients with AIDS Bernard Lo, M.D., Thomas A. Rabin, M.D., Neal H. Cohen, M.D., Robert M. Wachter, M.D., John M. Luce, M.D., and Philip C. Hopewell, M.D. Neurological Manifestations of Human Immunodeficiency Virus Infec tions Justin C. McArthur, M.B., B.S. Models of AIDS in the Light of Other Natural Lentivirus Infections in Domestic Animals Opendra Narayan, D.V.M., Ph.D. Social Science Research Relating to AIDS: Existing Knowledge and Research Needs Dorothy Nelkin, Ph.D. An Overview of Pediatric AIDS: Approaches to Diagnosis and Outcome Assessment Wade P. Parks, M.D., Ph.D., and Gwendolyn B. Scott, M.D. Issues of Ethics, Cost, and the Utilization of Scarce Medical Resources in the Terminal Care of AIDS Patients Thomas A. Raff n, M.D., and Bernard Lo, M.D. Intensive Care for Patients with the Acquired Immunodeficiency Syndrome Thomas A. Rabin, M3., Bernard Lo, M.D., Robert M. Wachter, M.D., John M. Luce, M.D., and Neal H. Cohen, M.D. Federal Funding for AIDS: Decision Process and Results Michael Stoto, Ph.D., David Blumenthal, M.D., M.P.P., Jane S. Durch, M.A., and Penny H. Feldman, Ph.D. Mechanisms of Cell Killing Cytopathic Effects by Retroviruses Howard M. Temin, Pn.D. Public Perceptions, Plural and Individual Behaviors in Response to AIDS Epidemic: Present Knowledge Charles Turner, Ph.D. Approaches to Understanding the Pathogenic Mechanisms in AIDS Irving Weissman, M.D. ission of AIDS in Africa
Representative terms from entire chapter: